According to the Zhitong Finance App, Zhongke Biotech (01237.HK) announced the 2026 interim results. The group achieved revenue of RMB 242 million during the period, an increase of 21.27% over the previous year; profit attributable to the company owners was 15.72 million yuan, an increase of 79.62% over the previous year; and the basic profit per share was 0.1,637 yuan.

According to the Zhitong Finance App, Zhongke Biotech (01237.HK) announced the 2026 interim results. The group achieved revenue of RMB 242 million during the period, an increase of 21.27% over the previous year; profit attributable to the company owners was 15.72 million yuan, an increase of 79.62% over the previous year; and the basic profit per share was 0.1,637 yuan.